Treatment outcomes for isoniazid-monoresistant tuberculosis in Peru, 2012-2014.

Treatment outcomes for isoniazid-monoresistant tuberculosis in Peru, 2012-2014.

<h4>Background</h4>Resistance to isoniazid is the most common form of drug-resistance in tuberculosis. However only a tiny proportion of TB patients in the world have access to isoniazid drug susceptibility testing-the widely implemented Xpert MTB/RIF technology only tests for resistance...

Full description

Bibliographic Details
Main Authors: Jose Gabriel Cornejo Garcia, Valentina Antonieta Alarcón Guizado, Alberto Mendoza Ticona, Edith Alarcon, Einar Heldal, David A J Moore
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0206658

Internet

https://doi.org/10.1371/journal.pone.0206658

Similar Items